Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation

NCT05492760 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2022-08-09

No results posted yet for this study

Summary

The recurrence of atrial fibrillation(AF) after pulmonary vein ablation with cryoballoon is conducted by many factors . The previous studies found larger left atrial and longer AF duration are tied to higher risk of AF recurrence. The characters of ablation procedure is also of critical importance to durable clinical success such as temperature features and time-to-isolation (TTI). The aim of our study is to develop an tool of recurrence risk evaluation with both pre-procedure and procedure factors.

Conditions

Interventions

DEVICE

cryoballoon ablation

Patients with AF will accept cryoballoon ablation.

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yawei Xu, doctor · Shanghai 10th People's Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-07-01
Completion
2024-07-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492760 on ClinicalTrials.gov